These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 22456178)
21. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs. Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837 [TBL] [Abstract][Full Text] [Related]
22. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells. Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627 [TBL] [Abstract][Full Text] [Related]
23. Death receptor 4 is preferentially recruited to lipid rafts in chronic lymphocytic leukemia cells contributing to tumor necrosis related apoptosis inducing ligand-induced synergistic apoptotic responses. Xiao W; Ishdorj G; Sun J; Johnston JB; Gibson SB Leuk Lymphoma; 2011 Jul; 52(7):1290-301. PubMed ID: 21699383 [TBL] [Abstract][Full Text] [Related]
24. Bufalin enhances TRAIL-induced apoptosis by redistributing death receptors in lipid rafts in breast cancer cells. Yan S; Qu X; Xu L; Che X; Ma Y; Zhang L; Teng Y; Zou H; Liu Y Anticancer Drugs; 2014 Jul; 25(6):683-9. PubMed ID: 24710190 [TBL] [Abstract][Full Text] [Related]
25. TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex. Kim J; Kang D; Sun BK; Kim JH; Song JJ Cell Signal; 2013 Jan; 25(1):372-9. PubMed ID: 23085457 [TBL] [Abstract][Full Text] [Related]
26. Constitutive localization of DR4 in lipid rafts is mandatory for TRAIL-induced apoptosis in B-cell hematologic malignancies. Marconi M; Ascione B; Ciarlo L; Vona R; Garofalo T; Sorice M; Gianni AM; Locatelli SL; Carlo-Stella C; Malorni W; Matarrese P Cell Death Dis; 2013 Oct; 4(10):e863. PubMed ID: 24136227 [TBL] [Abstract][Full Text] [Related]
27. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
28. Expression of c-Cbl, Cbl-b, and epidermal growth factor receptor in gastric carcinoma and their clinical significance. Dong Q; Liu YP; Qu XJ; Hou KZ; Li LL Chin J Cancer; 2010 Jan; 29(1):59-64. PubMed ID: 20038312 [TBL] [Abstract][Full Text] [Related]
29. Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression. Shrader M; Pino MS; Lashinger L; Bar-Eli M; Adam L; Dinney CP; McConkey DJ Cancer Res; 2007 Feb; 67(4):1430-5. PubMed ID: 17308080 [TBL] [Abstract][Full Text] [Related]
30. The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway. Lim SC; Parajuli KR; Han SI Tumour Biol; 2016 May; 37(5):6205-16. PubMed ID: 26615420 [TBL] [Abstract][Full Text] [Related]
31. Apple procyanidins activate apoptotic signaling pathway in human colon adenocarcinoma cells by a lipid-raft independent mechanism. Maldonado-Celis ME; Bousserouel S; Gossé F; Lobstein A; Raul F Biochem Biophys Res Commun; 2009 Oct; 388(2):372-6. PubMed ID: 19666002 [TBL] [Abstract][Full Text] [Related]
32. Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway. Cao Y; Qu J; Li C; Yang D; Hou K; Zheng H; Liu Y; Qu X Tumour Biol; 2015 Jul; 36(7):5607-15. PubMed ID: 25701378 [TBL] [Abstract][Full Text] [Related]
33. Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mérino D; Lalaoui N; Morizot A; Schneider P; Solary E; Micheau O Mol Cell Biol; 2006 Oct; 26(19):7046-55. PubMed ID: 16980609 [TBL] [Abstract][Full Text] [Related]
34. c-Cbl shRNA-expressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4/5. Kim SY; Kim JH; Song JJ Cancer Gene Ther; 2013 Feb; 20(2):82-7. PubMed ID: 23306613 [TBL] [Abstract][Full Text] [Related]
35. E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells. Xu L; Zhang Y; Qu X; Che X; Guo T; Cai Y; Li A; Li D; Li C; Wen T; Fan Y; Hou K; Ma Y; Hu X; Liu Y Neoplasia; 2017 Apr; 19(4):374-382. PubMed ID: 28334634 [TBL] [Abstract][Full Text] [Related]
36. Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Gajate C; Mollinedo F Blood; 2007 Jan; 109(2):711-9. PubMed ID: 17003375 [TBL] [Abstract][Full Text] [Related]
37. Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells. Liu Y; Chen L; Gong Z; Shen L; Kao C; Hock JM; Sun L; Li X Oncotarget; 2015 Feb; 6(5):3055-70. PubMed ID: 25605010 [TBL] [Abstract][Full Text] [Related]
38. c-Cbl acts as a mediator of Src-induced activation of the PI3K-Akt signal transduction pathway during TRAIL treatment. Song JJ; Kim JH; Sun BK; Alcala MA; Bartlett DL; Lee YJ Cell Signal; 2010 Mar; 22(3):377-85. PubMed ID: 19861161 [TBL] [Abstract][Full Text] [Related]
39. cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors. Ettenberg SA; Rubinstein YR; Banerjee P; Nau MM; Keane MM; Lipkowitz S Mol Cell Biol Res Commun; 1999 Aug; 2(2):111-8. PubMed ID: 10542134 [TBL] [Abstract][Full Text] [Related]
40. Redistribution of DR4 and DR5 in lipid rafts accounts for the sensitivity to TRAIL in NSCLC cells. Ouyang W; Yang C; Liu Y; Xiong J; Zhang J; Zhong Y; Zhang G; Zhou F; Zhou Y; Xie C Int J Oncol; 2011 Dec; 39(6):1577-86. PubMed ID: 21769428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]